In addition, the phosphorylation of key molecular CDC2 involved in the G2/M checkpoint was downregulated upon the knockdown of E-cadherin, which can enhance the anti-tumor activity of the Wee1 inhibitor AZD1775 by impairing the G2/M checkpoint and promoting premature mitosis. Here, WEE1 is linked to neoplasm.